Asparaginyl endopeptidase contributes to cetuximab resistance via MEK/ERK signaling in RAS wide-type metastatic colorectal cancer

BACKGROUND: Cetuximab, a monoclonal antibody targeting epidermal growth factor receptor (EGFR), is effective for RAS wild-type metastatic colorectal cancer (mCRC) patients. However, cetuximab resistance often occur and the mechanism has not been fully elucidated. The purpose of this study was to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaojing, Liu, Mengling, Peng, Ke, Yu, Yiyi, Liu, Tianshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941237/
https://www.ncbi.nlm.nih.gov/pubmed/36609651
http://dx.doi.org/10.1007/s12094-022-02986-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941237/
https://www.ncbi.nlm.nih.gov/pubmed/36609651
http://dx.doi.org/10.1007/s12094-022-02986-6

Ejemplares similares